UPDATE: Oppenheimer Upgrades Emerson To Outperform, Raises PT To $74

Loading...
Loading...
Oppenheimer is upgrading shares of Emerson
EMR
to Outperform from Perform, based on: valuation in line with other industrials in coverage vs. historical premium; best-in-class developing markets exposure and breadth of other exposures with secular growth characteristics; above average 2011 earnings growth; and significant economies of scale to guard long-term leadership positions globally. Emerson's Network Power trailing three-month organic orders through February were flat to down 5%, vs. 12-13% organic guidance. Oppenheimer believes data center backlog provides some visibility support, with primary weakness in embedded power, which can face rapid demand shifts, so a timing explanation could bridge the current differential vs. guidance. Oppenheimer views longer-term through-the-cycle visibility as currently under-appreciated. EMR's 34% emerging markets exposure and secular demand growth elements around PM, IA, CT, and NP are all drivers. Emerson closed Tuesday at $59.58
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsElectrical Components & EquipmentIndustrialsOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...